Evidence map›Paper›PMID 41626660›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Microbial Detection in Community-Acquired Pleural Space Infections Using the BIOFIRE Joint Infection Panel and Individual Polymerase Chain Reaction Assays.

Portia Mira, Ruben Dyrhovden, Marit Gjerde Tellevik, Tomas Mikal Eagan, Abigail Krause, Oscar Lopez-Martinez, Matthew Wolf, Kaiser G Lim, Ryan M Kern, Eva Carmona Porquera and 2 more

Abstract readEvaluation Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Portia MiraDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-4093-2809
Ruben DyrhovdenDepartment of Microbiology, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0002-2486-5426
Marit Gjerde TellevikDepartment of Microbiology, Haukeland University Hospital, Bergen, Norway.
Tomas Mikal EaganDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0001-8725-9960
Abigail KrauseDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Oscar Lopez-MartinezDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Matthew WolfDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Kaiser G LimDivision of Pulmonary and Critical Care, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-4551-6559
Ryan M KernDivision of Pulmonary and Critical Care, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-6311-2881
Eva Carmona PorqueraDivision of Pulmonary and Critical Care, Mayo Clinic, Rochester, Minnesota, USA.
Oyvind KommedalDepartment of Microbiology, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0002-4390-0370
Robin PatelDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6344-4141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew insights into community-acquired pleural infection microbiology may enable development of more rapid and accessible diagnostics that can streamline treatment. This study systematically compared molecular approaches for pathogen detection in pleural fluid from patients with such infections. Considering the need for rapid results with minimum hands-on time and test complexity, off-label use of the cassette-based, random-access BIOFIRE Joint Infection Panel (BF-JIP, bioMérieux) with and without supplementary in-house polymerase chain reaction (PCR) assays was evaluated.

methodsPleural fluids from 162 subjects from the Mayo Clinic (Rochester, Minnesota) and Haukeland University Hospital (Bergen, Norway), where molecular tests are routinely used for analyzing pleural fluid, were studied. The performance of the BF-JIP was compared to 16S rRNA gene PCR followed by Sanger and/or next-generation sequencing (16S rRNA gene PCR/sequencing), an in-house PCR panel specifically designed for pleural space infections, and culture.

resultsThe BF-JIP supplemented with 3 in-house PCR assays targeting Fusobacterium nucleatum group, Streptococcus intermedius/constellatus, and Aggregatibacter aphrophilus detected 96.8% of pleural infections, providing complete microbial profiles in 70.1%. In comparison, the detection rate of 16S rRNA gene PCR/sequencing was 92.2%, providing complete microbial profiles in 87.0%. Culture detected bacteria in only 31.9% of pleural fluids, providing complete microbial profiles in 15.3%.

conclusionsThese results underscore the importance of molecular approaches in diagnosing pleural space infections and demonstrate the feasibility of panel-based PCR-based diagnostics for these sometimes-complex infections. The BF-JIP, designed for testing synovial fluid, could be modified to provide a useful diagnostic for testing pleural fluid.

Indexed as

BacteriaCommunity-Acquired InfectionsMolecular Diagnostic TechniquesPleural DiseasesPolymerase Chain ReactionAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPleural EffusionRNA, Ribosomal, 16SSensitivity and SpecificityRNA, Ribosomal, 16Sempyemapleural space infectionsrapid molecular diagnostics

Identifiers

PMID41626660
PMCPMC13341233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.